INDP Indaptus Therapeutics Inc
Company Analysis
Latest News
🟢 Indaptus Therapeutics is trading 10.59% up today as biotechnology shares rebound
Indaptus Therapeutics is trading 10.59% up now at $3.55 as biotechnology shares rebound alongside a stronger broader market. - The biotech sector is...
🟢 Indaptus Therapeutics is trading 7.17% up today as biotechnology shares rebound
Indaptus Therapeutics is trading 7.17% up at $3.45 as biotechnology shares rebound and broader risk sentiment improves on September 17, 2026. - The sector is...
🔴 Indaptus Therapeutics is trading 10.16% down today as biotech sector declines
Indaptus Therapeutics is trading 10.16% down at $3.27 as biotech sentiment deteriorates, with XBI declining 2.11% during regular trading. - The decline...
🔴 Indaptus Therapeutics is trading 6.5% down today as biotech ETF XBI falls
Indaptus Therapeutics is trading 6.5% down now at $3.40, with the decline appearing primarily sector-driven. - Biotech ETF XBI was down 2.11% during regular...
🟢 Indaptus Therapeutics is trading 12.74% up today after a $24 million private placement
Indaptus Therapeutics is trading 12.74% up at $3.54 as investors continue responding to its September 10 announcement of an approximately $24 million private...
🟢 Indaptus Therapeutics is trading 6.37% up today after $24 million private placement
Indaptus Therapeutics is trading $3.34 (+6.37%) after continued investor response to its September 10 announcement of a private placement raising approximately...
🟢 Indaptus Therapeutics is trading 10.4% up today after a roughly $24 million private placement
Indaptus Therapeutics is trading 10.43% up now at $3.06 as investors continue responding to the September 10 private-placement announcement. • Financing...
🟢 Indaptus Therapeutics is trading 7.57% up today after a roughly $24 million private placement
Indaptus Therapeutics is trading at $2.98 (+7.57%) as investors continue responding to the company’s September 10 private-placement announcement. • Financing...
🟢 Indaptus Therapeutics is trading 12.57% up today after announcing a roughly $24 million private placement
Indaptus Therapeutics is trading 12.57% up now at $2.88 after announcing a roughly $24 million private placement on September 10, 2026. - The financing covers...
🟢 Indaptus Therapeutics is trading 8.6% up today after announcing a roughly $24 million private placement
Indaptus Therapeutics is trading 8.6% up now at $2.78 after its September 10, 2026 announcement of a roughly $24 million private placement. - The financing...
🟢 Indaptus Therapeutics is trading 5.9% up in pre-market after announcing $24 million private placement
Indaptus Therapeutics is trading 5.9% up now at $2.71 after announcing a roughly $24 million private placement of approximately 20.3 million shares on...
Indaptus Raises $24 Million as Its Stock Doubles in a Week — But Can a Cash-Burning Biotech With a Paused Drug Trial Justify the Momentum?
Shares of Indaptus Therapeutics (INDP) surged +15.9% to $2.41 on September 10, capping a week in which the stock roughly doubled from $1.17, after the company...
🟢 Indaptus Therapeutics is trading 15.87% up today after announcing a $24 million private placement
Indaptus Therapeutics is trading at $2.41, up 15.87% after announcing a $24 million private placement. - The financing includes 20,338,974 common shares and...
Indaptus Therapeutics Announces $24 Million Private Placement of Common Stock
Indaptus Therapeutics, Inc. entered into a stock purchase agreement on September 8, 2026, to sell 20,338,974 shares of its common stock in a private placement,...
🔴 Indaptus Therapeutics is trading 6.15% down in pre-market with no confirmed company-specific catalyst
Indaptus Therapeutics is trading 6.15% down at $1.95 after no confirmed company-specific catalyst was identified for September 10, 2026. - Available coverage...
🟢 Indaptus Therapeutics is trading 16.71% up today — No confirmed company-specific catalyst identified
Indaptus Therapeutics is trading 16.71% up now at $2.16, with no confirmed company-specific catalyst identified for the September 9 move. - It rose 51.64% to...
🔴 Indaptus Therapeutics is trading 5.4% down in pre-market with no confirmed catalyst
Indaptus Therapeutics is trading at $1.75, down 5.41%, with no confirmed company-specific catalyst identified for the September 9 pre-market decline. • Closed...
🔴 Indaptus Therapeutics is trading 6.45% down in after-hours trading with no confirmed company-specific catalyst
Indaptus Therapeutics is trading 6.45% down in after-hours trading at $1.73, with no confirmed company-specific announcement or late-breaking catalyst...
🟢 Indaptus Therapeutics is trading 11.48% up today with no confirmed company-specific catalyst
Indaptus Therapeutics is trading 11.48% up at $1.36, after rising from the September 4 close of $1.22, with no confirmed company-specific catalyst identified...
🟢 Indaptus Therapeutics is trading 5.74% up today with no confirmed company-specific catalyst
Indaptus Therapeutics is trading 5.74% up at $1.29, with no confirmed company-specific catalyst identified for the September 8, 2026 move. - The stock rose...